Robert Horne v. HHS - Influenza, Guillain-Barré syndrome (2024)
Case summary [AI summaries can sometimes make mistakes]
Robert Horne filed a petition for compensation under the National Vaccine Injury Compensation Program on October 27, 2023, alleging that he suffered from Guillain-Barré syndrome (GBS) as a result of receiving an influenza vaccination on October 26, 2022. He further alleged that he suffered residual effects for more than six months.
The respondent, the Secretary of Health and Human Services, filed a Rule 4(c) report conceding that Mr. Horne is entitled to compensation.
The respondent agreed that Mr. Horne satisfied the criteria set forth in the Vaccine Injury Table and the Qualifications and Aids to Interpretation for GBS following the administration of a seasonal flu vaccination.
Based on the respondent's concession and the evidence of record, Chief Special Master Brian H. Corcoran found that Mr.
Horne is entitled to compensation. The case is proceeding to determine the award amount.
The public decision does not describe the specific onset of symptoms, diagnostic tests, treatments, or expert witnesses. Petitioner counsel was Jimmy A.
Zgheib of Zgheib Sayad, P.C. Respondent counsel was Madylan Louise Yarc of the U.S.
Department of Justice.
Theory of causation
Petitioner Robert Horne received an influenza vaccination on October 26, 2022, and subsequently alleged Guillain-Barré syndrome (GBS) with residual effects lasting more than six months. The respondent conceded entitlement, agreeing that Petitioner met the criteria in the Vaccine Injury Table and Qualifications and Aids to Interpretation for GBS following seasonal flu vaccination. The public text does not specify the mechanism of injury, expert testimony, or detailed clinical findings. The case was decided by Chief Special Master Brian H. Corcoran on August 13, 2024, with entitlement granted pending damages. Petitioner counsel was Jimmy A. Zgheib, and respondent counsel was Madylan Louise Yarc.
Source PDFs
USCOURTS-cofc-1_23-vv-01906